First Tracks Biotherapeutics, Inc. TRAXV
$17.66
▲ +3.67% 24H
About
First Tracks Biotherapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing immunology therapeutics targeting autoimmune and inflammatory diseases. The company focuses on advancing innovative treatments within the immunology sector, addressing unmet medical needs in conditions characterized by …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees0
TickerTRAXV
Statistics
Market Cap$613.5M
Revenue (TTM)$0
Net Income-$163.7M
Net Margin—
EPS—
P/E—
P/S—
P/B2.38
EV/EBITDA-2.83
ROE-41.8%
Dividend Yield—
Price$17.66
Data: Twelve Data · Revenue = mcap / P/S